Letermovir for preventing cytomegalovirus infection after a kidney transplant (terminated appraisal) (TA1082)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 July 2025
Maribavir for treating refractory cytomegalovirus infection after transplant (TA860)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 18 January 2023
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease (TA809)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 July 2022
Immunosuppressive therapy for kidney transplant in adults (TA481)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 11 October 2017
Immunosuppressive therapy for kidney transplant in children and young people (TA482)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 11 October 2017
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation (CG135)Product type:GuidanceProgramme:Clinical guidelineLast updated: 21 December 2016Published: 12 December 2011
Everolimus for preventing organ rejection in liver transplantation (TA348)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Machine perfusion systems and cold static storage of kidneys from deceased donors (TA165)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 January 2009
OrganOx metra for liver transplant (MIB275)Product type:AdviceProgramme:Medtech innovation briefingPublished: 14 September 2021
Hemosep for cell salvage (MIB103)Product type:AdviceProgramme:Medtech innovation briefingPublished: 3 May 2017
OCS Heart system for heart transplant (MIB86)Product type:AdviceProgramme:Medtech innovation briefingPublished: 29 November 2016
Blood transfusion - Tranexamic acid (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 26 February 2026
Ex-situ machine perfusion devices for deceased donor liver transplantsStatus:In developmentProgramme:Health technology evaluationExpected publication date: 20 August 2026
In-situ normothermic regional perfusion of the abdomen for livers donated after controlled circulatory deathStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 19 November 2026
Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
XVIVO hypothermic perfusion of the DCD heartStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Dermal allograft augmentation in proximal humerus fracture fixationStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Ex-situ machine perfusion devices for extracorporeal preservation of lungs for transplantStatus:In developmentProgramme:Health technology evaluationExpected publication date: TBC